Genomics | Tissue Analysis

Tissue Analysis

The Company is working to develop and commercialize its proprietary Photoblaster™ instrument, a microdisplay-based optical instrument and accompanying consumables that employs photosensitive thin-films to analyze selected cell groups from normal and pathologic tissue sections at high-resolution.  These development efforts are supported by a three-year Fast-Track grant from the National Cancer Institute (NCI, IMAT Program).

The instrumentation and consumables being developed are based on proprietary Biolithography™ technology as described in the Company's U.S. Patent 6,159,681.  In addition to high-resolution tissue analysis, the Company is seeking to use the Photoblaster™ system as a facile system to generate high-density antibody arrays directly on two-dimensional tissue sections, suitable for direct proteomic analysis of normal and pathologic tissue sections.